Yesterday researchers from the Centers for Disease Control and Prevention (CDC) published encouraging findings that showed the antiviral remdesivir and antibodies in the ZMapp treatment regimen were effective in fighting the current strain of Ebola. The findings were published in The Lancet Infectious Diseases.

The study also demonstrated that a reverse-engineered virus that CDC scientists developed served as an admirable substitute for virus circulating in the Democratic Republic of the Congo (DRC), given that they did not have access to the real thing.

Test of 2 field treatments


Credit: CDC Cynthia Goldsmith

Read more at CIDRAP…

See also:

Jul 9 Lancet Infect Dis study

Jul 9 CDC press release

Jul 9 Stat article

Jul 9 Nature editorial

Jul 10 WHO situational report

WHO Ebola dashboard

Jul 9 DRC report

Photo credit:  U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)